The FDA's ruling means: After April 22, 2025, 503A pharmacies must stop compounding, likely cutting off a key supply source for practices
Thus, many researchers have highlighted the relationship between depressive behavior and metabolic alterations from various perspectives
Outinen PA, Sood SK, Liaw PCY, Sarge KD, Maeda N, Hirsh J, Ribau J, Podor TJ, Weitz JI, and Austin RC (1998)
New or worsening symptoms after starting metformin or adjusting the dose, even if they seem unrelated to blood pressure
The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice